Anti-IL-6 Antibody, Mouse Monoclonal (10395-MM72T)

Anti-IL-6抗体, Mouse Monoclonal

反应种属:Human
抗原名称:IL-6
应用:ELISA
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
ELISA1:1000-1:2000
ELISA(Det)1:1000-1:10000

推荐稀释说明

Optimal concentrations/dilutions should be determined by the end user.

详细信息

免疫原Recombinant Human IL-6 Protein (Catalog#10395-HNAE)
宿主/亚型Monoclonal Mouse IgG1 Clone #72
抗体类型Monoclonal
产品类型Antibody
克隆号72
产品形式Liquid
偶联物Unconjugated
纯化方式Protein A
储存缓冲液0.2 μm filtered solution in PBS
储存条件This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

特异性

Human IL-6

制备方法

This product is a recombinant monoclonal antibody expressed from HEK293 cells.

运输条件

This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

背景信息

Interleukin-6 (IL-6) is a multifunctional α-helical cytokine that regulates cell growth and differentiation of various tissues, which is known particularly for its role in the immune response and acute phase reactions. IL-6 protein is secreted by a variety of cell types including T cells and macrophages as a phosphorylated and variably glycosylated molecule. It exerts actions through its heterodimeric receptor composed of IL-6R that lacks the tyrosine/kinase domain and binds IL-6 with low affinity, and ubiquitously expressed glycoprotein 130 (gp130) that binds the IL-6. IL-6R complex with high affinity and thus transduces signals. IL-6 is also involved in hematopoiesis, bone metabolism, and cancer progression, and has been defined as an essential role in directing the transition from innate to acquired immunity. Cancer Immunotherapy Immune Checkpoint Immunotherapy Targeted Therapy Full Name interleukin 6 Research Areas Neuroinflammation Cancer Drug Targets Related Pathways IL17 signaling pathway References Heinrich PC. et al. (2003). Principles of interleukin-6-type cytokine signalling and its regulation. Biochem J. 374: 1-20. Rose-John S, et al. (2007) The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets. 11(5): 613-24. Dinh W, et al. (2009) Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol. 8:58.